| GSK | 20-Feb-26 |
Buy |
Hal Barron |
4,415.59p | 64 |
£2,825.98 |
| GSK | 20-Feb-26 |
Buy Dividends |
Hal Barron |
4,415.59p | 2,007,552 |
£88,645,348.67 |
| GSK | 20-Feb-26 |
Buy |
Wendy Becker |
2,219.26p | 3,334 |
£73,990.13 |
| GSK | 20-Feb-26 |
Buy Dividends |
Hal Barron |
4,415.59p | 2,007,552 |
£88,645,348.67 |
| GSK | 20-Feb-26 |
Buy |
Wendy Becker |
2,219.26p | 3,334 |
£73,990.13 |
| GSK | 20-Feb-26 |
Buy |
Hal Barron |
4,415.59p | 64 |
£2,825.98 |
| BVC |
13.38p |
+4.1% |
| FLTR |
8,898.00p |
+2.8% |
| SGE |
803.40p |
+2.1% |
| RM. |
101.00p |
+2.0% |
| NCC |
131.80p |
+2.0% |
| DIA |
306.00p |
+2.0% |
| BT.A |
213.20p |
+1.9% |
| SN. |
1,346.00p |
+1.5% |
| XPP |
1,398.00p |
+1.3% |
| VOD |
117.75p |
+1.3% |
| OXB |
632.00p |
-7.5% |
| QQ. |
498.60p |
-1.7% |
| BA. |
2,106.00p |
-1.6% |
| APTD |
237.00p |
-1.3% |
| OXIG |
2,640.00p |
-0.6% |
Top of Page
You are here:
research